{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:18:09Z","timestamp":1790212689573,"version":"4.1.0"},"reference-count":22,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although HMGA1 (high-mobility group A1; formerly HMG-I\/Y) is an oncogene that is widely overexpressed in aggressive cancers, the molecular mechanisms underlying transformation by HMGA1 are only beginning to emerge. HMGA1 encodes the HMGA1a and HMGA1b protein isoforms, which function in regulating gene expression. To determine how HMGA1 leads to neoplastic transformation, we looked for genes regulated by HMGA1 using gene expression profile analysis. Here, we show that the STAT3 gene, which encodes the signaling molecule signal transducer and activator of transcription 3 (STAT3), is a critical downstream target of HMGA1a. STAT3 mRNA and protein are up-regulated in fibroblasts overexpressing HMGA1a and activated STAT3 recapitulates the transforming activity of HMGA1a in fibroblasts. HMGA1a also binds directly to a conserved region of the STAT3 promoter in vivo in human leukemia cells by chromatin immunoprecipitation and activates transcription of the STAT3 promoter in transfection experiments. To determine if this pathway contributes to HMGA1-mediated transformation, we investigated STAT3 expression in our HMGA1a transgenic mice, all of which developed aggressive lymphoid malignancy. STAT3 expression was increased in the leukemia cells from our transgenics but not in control cells. Blocking STAT3 function induced apoptosis in the transgenic leukemia cells but not in controls. In primary human leukemia samples, there was a positive correlation between HMGA1a and STAT3 mRNA. Moreover, blocking STAT3 function in human leukemia or lymphoma cells led to decreased cellular motility and foci formation. Our results show that the HMGA1a\u2013STAT3 axis is a potential Achilles heel that could be exploited therapeutically in hematopoietic and other malignancies overexpressing HMGA1a. [Cancer Res 2008;68(24):10121\u20137]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-2121","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T03:33:36Z","timestamp":1229312016000},"page":"10121-10127","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["The High-Mobility Group A1a\/Signal Transducer and Activator of Transcription-3 Axis: An Achilles Heel for Hematopoietic Malignancies?"],"prefix":"10.1158","volume":"68","author":[{"given":"Joelle","family":"Hillion","sequence":"first","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Dhara","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"},{"name":"3Pediatrics,"},{"name":"4Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takita Felder","family":"Sumter","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"},{"name":"3Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mita","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"},{"name":"3Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francescopaolo","family":"Di Cello","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Belton","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Turkson","sequence":"additional","affiliation":[{"name":"6BioMolecular Science Center and"},{"name":"7Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souyma","family":"Jaganathan","sequence":"additional","affiliation":[{"name":"6BioMolecular Science Center and"},{"name":"7Department of Molecular Biology and Microbiology, University of Central Florida, Orlando, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhao","family":"Cheng","sequence":"additional","affiliation":[{"name":"4Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Ye","sequence":"additional","affiliation":[{"name":"4Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jove","sequence":"additional","affiliation":[{"name":"8Experimental Therapeutics Program, City of Hope Comprehensive Cancer Center and"},{"name":"9Division of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Aplan","sequence":"additional","affiliation":[{"name":"10National Cancer Institute, Center for Cancer Research, Genetics Branch, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Wei","family":"Lin","sequence":"additional","affiliation":[{"name":"10National Cancer Institute, Center for Cancer Research, Genetics Branch, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Wertzler","sequence":"additional","affiliation":[{"name":"11Washington State University, Pullman, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Reeves","sequence":"additional","affiliation":[{"name":"11Washington State University, Pullman, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Elbahlouh","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"},{"name":"3Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Kowalski","sequence":"additional","affiliation":[{"name":"5Biostatistics, The Johns Hopkins University School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raka","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"},{"name":"3Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M. S.","family":"Resar","sequence":"additional","affiliation":[{"name":"1Hematology Division and"},{"name":"2Departments of Medicine,"},{"name":"3Pediatrics,"},{"name":"4Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,12,15]]},"reference":[{"key":"2022061700273499800_B1","doi-asserted-by":"crossref","unstructured":"Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer\u20082007; 7: 899\u2013910.","DOI":"10.1038\/nrc2271"},{"key":"2022061700273499800_B2","doi-asserted-by":"crossref","unstructured":"Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene\u20082001; 277: 63\u201381.","DOI":"10.1016\/S0378-1119(01)00689-8"},{"key":"2022061700273499800_B3","doi-asserted-by":"crossref","unstructured":"Wood LJ, Mukherjee M, Dolde CE, et al. HMG-I\/Y: a new c-Myc target gene and potential oncogene. Mol Cell Biol\u20082000; 20: 5490\u2013502.","DOI":"10.1128\/MCB.20.15.5490-5502.2000"},{"key":"2022061700273499800_B4","unstructured":"Wood LJ, Maher JF, Bunton TE, Resar LMS. The oncogenic properties of the HMG-I gene family. Cancer Res\u20082000; 60: 4256\u201361."},{"key":"2022061700273499800_B5","doi-asserted-by":"crossref","unstructured":"Reeves R, Edberg DD, Ying L. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol\u20082001; 21: 575\u201394.","DOI":"10.1128\/MCB.21.2.575-594.2001"},{"key":"2022061700273499800_B6","doi-asserted-by":"crossref","unstructured":"Takaha N, Resar LM, Vindivich D, Coffey DS. High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells. Prostate\u20082004; 60: 160\u20137.","DOI":"10.1002\/pros.20049"},{"key":"2022061700273499800_B7","doi-asserted-by":"crossref","unstructured":"Scala S, Portella G, Fedele M, Chiapetta G, Fusco A. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci U S A\u20082000; 85: 6047\u201351.","DOI":"10.1073\/pnas.070029997"},{"key":"2022061700273499800_B8","doi-asserted-by":"crossref","unstructured":"Xu Y, Sumter Felder T, Bhattacharya R, et al. The HMG-I oncogene causes highly penetrant, metastatic lymphoid malignancy in transgenic mice and is overexpressed in human lymphoid malignancy. Cancer Res\u20082004; 64: 3371\u201375.","DOI":"10.1158\/0008-5472.CAN-04-0044"},{"key":"2022061700273499800_B9","doi-asserted-by":"crossref","unstructured":"Fedele M, Pentimalli F, Baldassarre G, et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone\/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene\u20082005; 24: 3427\u201335.","DOI":"10.1038\/sj.onc.1208501"},{"key":"2022061700273499800_B10","doi-asserted-by":"crossref","unstructured":"Tesfaye A, Di Cello F, Hillion J, et al. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res\u20082007; 67: 3998\u20134004.","DOI":"10.1158\/0008-5472.CAN-05-1684"},{"key":"2022061700273499800_B11","doi-asserted-by":"crossref","unstructured":"Munshi N, Yie Y, Merika M, et al. The IFN-\u03b2 enhancer: a paradigm for understanding activation and repression of inducible gene expression. Cold Spring Harb Symp Quant Biol\u20081999; 64: 149\u201359.","DOI":"10.1101\/sqb.1999.64.149"},{"key":"2022061700273499800_B12","doi-asserted-by":"crossref","unstructured":"Treff NR, Dement GA, Adair JE, et al. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells. Oncogene\u20082004; 23: 8557\u201362.","DOI":"10.1038\/sj.onc.1207926"},{"key":"2022061700273499800_B13","doi-asserted-by":"crossref","unstructured":"Treff NR, Pouchnik D, Dement GA, Britt RL, Reeves R. High-mobility group A1a protein regulates Ras\/ERK signaling in MCF-7 human breast cancer cells. Oncogene\u20082004; 23: 777\u201385.","DOI":"10.1038\/sj.onc.1207167"},{"key":"2022061700273499800_B14","doi-asserted-by":"crossref","unstructured":"Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE. Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol\u20081998; 18: 2553\u201358.","DOI":"10.1128\/MCB.18.5.2553"},{"key":"2022061700273499800_B15","doi-asserted-by":"crossref","unstructured":"Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell\u20081999; 98: 295\u2013303.","DOI":"10.1016\/S0092-8674(00)81959-5"},{"key":"2022061700273499800_B16","doi-asserted-by":"crossref","unstructured":"Yu H, Jove R. The STATs of cancer\u2014new molecular targets come of age. Nat Rev Cancer\u20082004; 4: 97\u2013105.","DOI":"10.1038\/nrc1275"},{"key":"2022061700273499800_B17","doi-asserted-by":"crossref","unstructured":"Turkson J, Zhang S, Palmer J, et al. Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. Mol Cancer Ther\u20082004; 3: 1533\u201342.","DOI":"10.1158\/1535-7163.1533.3.12"},{"key":"2022061700273499800_B18","doi-asserted-by":"crossref","unstructured":"Varga T, Aplan PD. Chromosomal aberrations induced by double strand DNA breaks. DNA Repair\u20082005; 4: 1038\u201346.","DOI":"10.1016\/j.dnarep.2005.05.004"},{"key":"2022061700273499800_B19","doi-asserted-by":"crossref","unstructured":"Kato K, Nomoto M, Izumi H, et al. Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the up-regulation in cisplatin-resistant cells. Biochem Biophys Acta\u20082000; 1493: 91\u2013100.","DOI":"10.1016\/S0167-4781(00)00168-8"},{"key":"2022061700273499800_B20","doi-asserted-by":"crossref","unstructured":"Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentivirus vectors. Science\u20082002; 295: 868\u201372.","DOI":"10.1126\/science.1067081"},{"key":"2022061700273499800_B21","doi-asserted-by":"crossref","unstructured":"Di Cello F, Hillion J, Kowalski J, et al. Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts. Mol Cancer Ther\u20082008; 7: 2090\u20135.","DOI":"10.1158\/1535-7163.MCT-07-2282"},{"key":"2022061700273499800_B22","doi-asserted-by":"crossref","unstructured":"Karhadkar SS, Bova SG, Abdallah N, et al. Hedgehog signaling in prostate regeneration, neoplasia, and metastasis. Nature\u20082004; 431: 701\u201312.","DOI":"10.1038\/nature02962"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/24\/10121\/2598468\/10121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/24\/10121\/2598468\/10121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:54:44Z","timestamp":1655427284000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/24\/10121\/541753\/The-High-Mobility-Group-A1a-Signal-Transducer-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,15]]},"references-count":22,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2008,12,15]]},"published-print":{"date-parts":[[2008,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-2121","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22377134.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377128.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498446","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377134","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498446.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377128","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,15]]}}}